Sildenafil is one of the most commonly used drugs for the treatment of erectile dysfunction. To date, we found five reported cases of intracerebral bleeding and two reported cases of subarachnoid hemorrhage related to sildenafil use. We report a 49-year-old hypertensive and diabetic patient who presented with acute pulmonary edema and loss of consciousness following ingestion of 100 mg of sildenafil prior to sexual intercourse. He was not previously aware of the presence of an aneurysm and had no family history of it. Computed tomography of his head revealed a subarachnoid hemorrhage due to rupture of a saccular aneurysm with subsequent repeat hemorrhage within a few hours of presentation. A sudden increase in blood pressure led to pulmonary edema. Studies have shown that sildenafil acts on phosphodiesterase-1, -2 and -5 receptors and leads to a secondary increase in intracerebral circulation and vasodilatory effects, leading to sympathetic overactivity which increases the risk for intracranial bleeding. S ildenafi l, marketed as Viagra, is a widely used phosphodiesterase (PDE)-5 inhibitor to treat male sexual/erectile dysfunction and to increase libido and sexual performance. Th e common adverse eff ects of this drug include headache, fl ushing, indigestion, and impaired vision. Five cases of intracerebral bleeding and two cases of subarachnoid hemorrhage (SAH) due to sildenafi l use have been reported ( 1 -7 ). We report a 49-year-old man who presented with a hypertensive crisis and an SAH caused by rupture of a saccular intracranial aneurysm during sexual intercourse following sildenafi l intake.
CASE REPORT
A 49-year-old man with diabetes mellitus and hypertension was brought in to the emergency department due to acute-onset shortness of breath and loss of consciousness during sexual intercourse. Th e patient had ingested 100 mg of sildenafi l prior to the event (unknown time gap). Reportedly, he was diaphoretic and short of breath and required intubation due to a low Glasgow Coma Scale score of <7. His blood pressure was 181/105 mm Hg with a mean arterial pressure of 124 mm Hg. His chest examination revealed bibasilar crackles. A neurological examination was not completed because the patient was sedated. His pupils were round and reactive with normal deep tendon refl exes, and he could localize the pain. Routine blood counts, platelet counts, and coagulation factors were normal. His chest x-ray revealed diff use bilateral opacities consistent with pulmonary edema. An electrocardiogram showed a normal sinus rhythm. An arterial blood gas showed high anion gap (29) metabolic acidosis with respiratory acidosis: pH 7.22; partial pressure of oxygen, 68 mm Hg; partial pressure of carbon dioxide, 42.7 mm Hg; bicarbonate, 17.1 mEq/L; and lactate, 4.7 mmol/L. Bedside transthoracic echocardiography showed normal systolic function with no regional wall motion abnormality and grade II diastolic dysfunction.
Computed tomography of the head showed a massive acute SAH with the largest blood collection in the area of the anterior communicating artery with mild hydrocephalus ( Figure 1 a) . Th e patient was started on mannitol 100 g over 30 minutes and underwent computed tomography angiogram of intracranial vessels, which showed an aneurysm at the junction of the right anterior cerebral artery and anterior communicating artery ( Figure 1 b) . He was urgently taken to the operating room and underwent ventriculostomy. While in the operating room, his ventricular pressures increased, his pupils dilated, suggesting brain herniation, and he underwent bilateral decompressive craniotomy and aneurysm clipping. Postoperatively, his Glasgow Coma Scale score was 3/15, and he was cooled to maintain temperature around 35°C for 48 hours. Because of his low Glasgow Coma Scale score, his chances for safe extubation seemed unlikely, and a tracheostomy and percutaneous endoscopic gastrostomy tube were placed on postoperative day 8. On postoperative day 10, he started to improve slowly, and his Glasgow Coma Scale increased to 15/15 on postoperative day 31. He continued to require a tracheostomy collar and was discharged to a neurorehabilitation institute.
DISCUSSION
Sildenafi l inhibits PDE-5-mediated hydrolysis of cyclic guanosine monophosphate (cGMP), leading to increased intracellular cGMP levels in the vascular smooth muscle of the corpus cavernosum and resulting in smooth muscle relaxation and arterial vasodilation ( 8 ) . Th e amount of cGMP in
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Avinash Adiga , MD, Hawa Edriss, MD, and Kenneth Nugent, MD Intracranial aneurysm and sildenafil April 2016 cerebrovascular smooth muscles is aff ected by nitric oxide and PDE. Nitric oxide activates guanylate cyclase in the cerebral arterial cells. Th e activated guanylate cyclase converts guanosine triphosphate to cGMP. Th e latter causes relaxation of vascular smooth muscle cells in the cerebral vasculature ( 9 , 10 ) .
Th e relationship between intracranial hemorrhage (ICH) and sildenafi l use is likely due to increased blood fl ow to the intracranial vessels, which is signifi cantly increased during sexual intercourse. Increased blood fl ow to the cerebral blood vessels facilitates rupture of the cerebrovascular vessels in patients with other hemorrhagic risk factors ( 3 ). Ballard et al suggested that sildenafi l also acts on PDE-1 and PDE-2, which are involved in controlling cerebral circulation ( 11 ) . Studies on mice have demonstrated that sildenafi l decreases cerebral vasospasm by increasing and restoring cGMP levels ( 12 ) . Th e reported adverse eff ects of sildenafi l include headache, visual disturbances, pupil-sparing third nerve palsy, and transient hypertension, and these symptoms suggest that sildenafi l also aff ects brain microvasculature regulation ( 13 , 14 ) . Unusual susceptibility to this drug could lead to abnormal vasodilatation of cerebral arteries and abnormal redistribution of arterial blood fl ow in the brain. Th e hypothetical relationship between ICH and sildenafi l ingestion is not well understood ( 2 , 5 ) . Transcranial Doppler studies have shown that sildenafi l increases cerebrovascular reactivity and causes vasodilation with increased blood fl ow and volume ( 15 ) . Th e vasodilatory eff ect of sildenafi l causes hypotension that could lead to an increase in sympathetic activity, which might be the reason for secondary hypertension leading to SAH, as occurred in our case. Ayberk et al reported a case of intracerebral bleed in a healthy 35-year-old man 3 hours after ingestion of 50 mg of sildenafi l without any sexual activity ( 5 ). Th is supports our conclusion that sildenafi l results in reactive sympathetic hyperactivity that leads to ICH regardless of the presence or absence of other risk factors, such as hypertension and sexual intercourse. Nevertheless, our known hypertensive patient had an elevated blood pressure and SAH after sildenafi l use. Whether the hypertensive crisis in this patient caused by sildenafi l was secondary to sympathetic hyperactivity or sexual intercourse or whether the ICH itself caused hypertension cannot be determined. Also, we do not know if there is a doserelated eff ect which causes ICH. All reported patients ingested 50 mg or more ( Table 1 ) . Sildenafi l citrate has been shown to be safe in patients without cardiovascular disease but is contraindicated in those with acute coronary syndromes, life-threatening coronary arrhythmias, and recent stroke. Th e US Food and Drug Administration advises cautioned use of sildenafi l in patients with a history of myocardial infarction or stroke within 6 months and those with resting hypotension, severe hypertension (<170/110 mm Hg), and heart failure ( 16 ) .
All fi ve previously reported intracerebral hemorrhages with sildenafi l use presented with minimal volume hemorrhage in elderly patients with a risk factor of ICH, and surgical evacuation was not required ( Table 1 ) ( 1 -5 ) . However, the previous two reports of SAH with sildenafi l use were associated with severe bleeding ( 6 , 7 ) . One patient required emergency decompression due to impending herniation, and the other patient was pronounced dead on arrival ( 6 , 7 ). Our patient rebled following the initial SAH and underwent ventriculostomy and bilateral decompressive craniotomy. His neurological status improved tremendously, and his Glasgow Coma Scale score was 15/15 on discharge. In conclusion, sildenafi l is a relatively safe and widely used medication to treat erectile dysfunction. However, serious complications, such as severe ICH and SAH, have been reported with its use.
